Screener
Ironwood Pharmaceuticals IRWD Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Interest expense and other financing costs | (7,203) | (8,356) | (16,344) | (16,426) |
| Interest and investment income | 1,585 | 818 | 3,283 | 1,687 |
| Other | 42 | 39 | 84 | 76 |
| Other income (expense), net | (5,576) | (7,499) | (12,977) | (14,663) |
| Income before income taxes | 73,731 | 37,822 | 138,903 | 1,550 |
| Income tax expense | (22,440) | (14,223) | (46,839) | (15,337) |
| Net income (loss) | $51,291 | $23,599 | $92,064 | $(13,787) |
| Net income (loss) per share — basic | $0.31 | $0.15 | $0.56 | $(0.09) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's other income (expense)?
- Ironwood Pharmaceuticals (IRWD) reported other income (expense) of -$5.58M in Q2 2026.
- How has Ironwood Pharmaceuticals's other income (expense) changed year-over-year?
- Ironwood Pharmaceuticals's other income (expense) increased by 25.6% year-over-year, from -$7.5M to -$5.58M.
- What is the long-term trend for Ironwood Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's other income (expense) has grown at a -2.6% compound annual growth rate (CAGR), from -$31.6M to -$28.48M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Ironwood Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude